Ad
Wednesday, 24 August 2016
Drug price hikes can damage company reputations: White House
WASHINGTON (Reuters) - The White House on Wednesday said pharmaceutical firms risked damaging their reputations with big price hikes, but it sidestepped commenting directly on Mylan NV's decision to raise the price of its severe allergy treatment drug EpiPen.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment